3 Bold Biotech Predictions For 2018


The biotech sector largely performed in line with the overall market in 2017, after under performing in 2015 and 2016. There are several reasons to believe that M&A activity picks up markedly in the New Year which will be a tailwind for the sector.



from Biotech News